ArticleCureus2026
Incomplete Patient Medication Histories Pose a Significant Barrier to Finding the Best Treatment Choices in Outpatient Community Care.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
When physicians consult patients with chronic conditions, they often need to make treatment decisions. Pharmacological strategies are based on different sources, including complete medication histories. However, a physician's access to a patient's medication history is usually limited to current medications and known allergies. This editorial examines gaps in outpatient medication documentation and argues for systematic improvements in how medication response data are collected and shared. We propose adding medication-related information to a patient's medical records that would facilitate determining effective treatment strategies, as these data are often neither collected nor presented in the medical history. The minimum required information includes data about medications discontinued due to adverse reactions, ineffectiveness, nonadherence, or excessive costs. In selected clinical contexts, pharmacogenetic testing may assist with treatment decision-making by identifying patients at higher risk of non-response or adverse effects. Based on a patient's genetic variations in drug metabolism, pharmacogenetic results may allow physicians to anticipate treatment response and personalize guideline-based therapy for chronic conditions. In this article, we discuss the absence of this necessary information in medical records and its implications for selecting safe and effective treatments across various medical specialties. We propose implementing structured documentation of medication failures and, where appropriate, integrating pharmacogenetic data within privacy-secured databases to support individualized outpatient care. Having more complete pharmacological data for each patient, including drugs previously tried without success or discontinued for various reasons, and ideally a genetic metabolic profile, could help clinicians identify the most appropriate drugs on an individual basis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.